Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.

Cusini A, Vernazza PL, Yerly S, Decosterd LA, Ledergerber B, Fux CA, Rohrbach J, Widmer N, Hirschel B, Gaudenz R, Cavassini M, Klimkait T, Zenger F, Gutmann C, Opravil M, G√ľnthard HF; Swiss HIV Cohort Study.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):28-35. doi: 10.1097/QAI.0b013e318274e2b0. Erratum in: J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):e170-1.

PMID:
23018371
2.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
3.

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir.

Le Tiec C, Barrail A, Goujard C, Taburet AM.

Clin Pharmacokinet. 2005;44(10):1035-50. Review.

PMID:
16176117
5.
6.

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Ferretti F, Gisslen M, Cinque P, Price RW.

Curr HIV/AIDS Rep. 2015 Jun;12(2):280-8. doi: 10.1007/s11904-015-0267-7. Review.

PMID:
25860317
7.

Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system.

Almeida SM.

Arq Neuropsiquiatr. 2015 Jul;73(7):624-9. doi: 10.1590/0004-282X20150071. Review.

8.

Neurologic complications of HIV disease and their treatment.

Letendre SL, Ellis RJ, Ances BM, McCutchan JA.

Top HIV Med. 2010 Apr-May;18(2):45-55. Review.

9.

Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Calcagno A, Di Perri G, Bonora S.

Clin Pharmacokinet. 2014 Oct;53(10):891-906. doi: 10.1007/s40262-014-0171-0. Review.

Supplemental Content

Support Center